MedPath
TGA Approval

ACTAIR Continuation Treatment 300IR sublingual tablets blister pack (233471)

233471

ACTAIR Continuation Treatment 300IR sublingual tablets blister pack

Stallergenes Australia Pty Ltd

April 15, 2016

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/cf188636ee1435ccfebe4a072f88e85d.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/1c7b17227eceb0eed024e8909b176c9d.pdf

Active Ingredients

American house dust mite

European house dust mite

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ACTAIR Continuation Treatment 300IR sublingual tablets blister pack (233471) - TGA 批准文号 | MedPath